Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on ICON plc

Share:
Related ICLR
Earnings Scheduled For February 25, 2015
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS
Is ICON Public Limited (ICLR) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat - Tale of the Tape (Zacks)

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on ICON plc (NASDAQ: ICLR), and raised its price target from $29.00 to $32.00.

Jefferies noted, “ICON's investor day focused on the competitive differentiation and margin leverage that should come from recent technology and informatics investments. With robust backlog growth, management's revenue outlook for 2013 appears conservative. Nonetheless, efficiency improvements, utilization, and centralized support should drive considerable margin improvement, likely to the 10%+ level before 2013 is over.”

ICON plc closed on Tuesday at $27.66.

Latest Ratings for ICLR

DateFirmActionFromTo
Apr 2015BarclaysMaintainsEqual-weight
Mar 2015SunTrust Robinson HumphreyMaintainsBuy
Feb 2015JefferiesMaintainsBuy

View More Analyst Ratings for ICLR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (ICLR)

Around the Web, We're Loving...